MRI techniques for prediction of local tumor progression after high-intensity focused ultrasonic ablation of prostate cancer

被引:79
作者
Kim, Chan Kyo [1 ,2 ]
Park, Byung Kwan [1 ,2 ]
Lee, Hyun Moo [3 ]
Kim, Sam Soo [4 ]
Kim, Eun Ju [5 ]
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul 135710, South Korea
[3] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Urol, Seoul 135710, South Korea
[4] Kangwon Natl Univ, Sch Med, Dept Radiol, Kangwon Do, South Korea
[5] Philips Healthcare Korea, Dept MRI, DIS Business Grp, Seoul, South Korea
关键词
diffusion-weighted MRI; dynamic contrast-enhanced MRI; high-intensity focused ultrasonic ablation; localized prostate cancer; MRI;
D O I
10.2214/AJR.07.2924
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to evaluate the diagnostic performance of dynamic contrast-enhanced MRI (DCE-MRI) and of T2-weighted MRI with diffusion-weighted imaging (DWI) for predicting local tumor progression after high-intensity focused ultrasonic ablation of localized prostate cancer. MATERIALS AND METHODS. Twenty-seven patients who had increased levels of prostate-specific antigen after high-intensity focused ultrasonic ablation underwent MRI and endorectal biopsy. The MR images and biopsy results were correlated for six prostate sectors. Residual or recurrent prostate cancer after treatment was defined as local tumor progression if the biopsy results showed cancer foci. Two readers blinded to the clinical findings and biopsy results used a 5-point scale to independently assess DCE-MR images and T2-weighted and diffusion-weighted MR images. The results were compared by use of the McNemar test with Bonferroni correction, generalized estimating equations, and receiver operating characteristic analysis. RESULTS. After high-intensity focused ultrasonic ablation, local tumor progression was pathologically detected in 54 (33%) of 162 sectors in 18 patients. The sensitivities of DCE-MRI and T2-weighted MRI with DWI were 80% and 63% for reader 1 (p=0.004) and 87% and 70% for reader 2 (p=0.004). The specificities of DCE-MRI and T2-weighted MRI with DWI were 68% and 78% for reader 1 (p=0.002) and 63% and 74% for reader 2 ( p < 0.001). The accuracy rates of DCE-MRI and T2-weighted MRI with DWI were 72% and 73% for reader 1 ( p > 0.05) and 71% and 73% for reader 2 ( p > 0.05). The areas under the receiver operating characteristic curve for DCE-MRI and T2-weighted MRI with DWI were 0.77 and 0.77 for reader 1 and 0.85 and 0.81 for reader 2. CONCLUSION. For prediction of local tumor progression of prostate cancer after high-intensity focused ultrasonic ablation, DCE-MRI was more sensitive than T2-weighted MRI with DWI, but T2-weighted MRI with DWI was more specific than DCE-MRI.
引用
收藏
页码:1180 / 1186
页数:7
相关论文
共 37 条
[1]   EAU guidelines on prostate cancer [J].
Aus, G ;
Abbou, CC ;
Bolla, M ;
Heidenreich, A ;
Schmid, HP ;
van Poppel, H ;
Wolff, J ;
Zattoni, F .
EUROPEAN UROLOGY, 2005, 48 (04) :546-551
[2]   Current status of HIFU and cryotherapy in prostate cancer - A review [J].
Aus, Gunnar .
EUROPEAN UROLOGY, 2006, 50 (05) :927-934
[3]   Targeted cryoablation of the prostate: 7-year outcomes in the primary treatment of prostate cancer [J].
Bahn, DK ;
Lee, F ;
Badalament, R ;
Kumar, A ;
Greski, J ;
Chernick, M .
UROLOGY, 2002, 60 (2A) :3-11
[4]   High-intensity focused ultrasound for the treatment of localized prostate cancer: 5-year experience [J].
Blana, A ;
Walter, B ;
Rogenhofer, S ;
Wieland, WF .
UROLOGY, 2004, 63 (02) :297-300
[5]   Prostate cancer: Evaluation of vascular characteristics with dynamic contrast-enhanced T1-weighted MR imaging - Initial experience [J].
Buckley, DL ;
Roberts, C ;
Parker, GJM ;
Logue, JP ;
Hutchinson, CE .
RADIOLOGY, 2004, 233 (03) :709-715
[6]  
Carriere KC, 2000, HEALTH SERV RES, V35, P467
[7]   Technology insight:: high-intensity focused ultrasound for urologic cancers [J].
Chaussy, C ;
Thüroff, S ;
Rebillard, X ;
Gelet, A .
NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (04) :191-198
[8]  
Chen ME, 2000, CANCER, V89, P1800, DOI 10.1002/1097-0142(20001015)89:8<1800::AID-CNCR21>3.0.CO
[9]  
2-D
[10]   Principles and results of high-intensity focused ultrasound for localized prostate cancer [J].
Colombel, M ;
Gelet, A .
PROSTATE CANCER AND PROSTATIC DISEASES, 2004, 7 (04) :289-294